ClinicalTrials.Veeva

Menu

Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction (GEMyCE 1)

S

State University of New York - Upstate Medical University

Status

Completed

Conditions

Myocardial Infarction

Study type

Observational

Funder types

Other

Identifiers

NCT01749683
GEMyCE1

Details and patient eligibility

About

The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 71 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG

Exclusion criteria

  • Patients are excluded if they are older than 70 year old, require mechanical ventilation, are receiving intravenous pressors or hemodynamic support, or if the motion of segments associated with infarct-related artery can not be accurately determined.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems